[HTML][HTML] The cyclic AMP signaling pathway: Exploring targets for successful drug discovery

KUO Yan, LN Gao, YL Cui… - Molecular medicine …, 2016 - spandidos-publications.com
During development of disease, complex intracellular signaling pathways regulate an
intricate series of events, including resistance to external toxins, the secretion of cytokines …

[HTML][HTML] Epigenetics of host–pathogen interactions: the road ahead and the road behind

E Gómez-Díaz, M Jorda, MA Peinado, A Rivero - PLoS pathogens, 2012 - journals.plos.org
A growing body of evidence points towards epigenetic mechanisms being responsible for a
wide range of biological phenomena, from the plasticity of plant growth and development to …

IGF2BP1 promotes SRF-dependent transcription in cancer in am6A- and miRNA-dependent manner

S Müller, M Glaß, AK Singh, J Haase… - Nucleic acids …, 2019 - academic.oup.com
The oncofetal mRNA-binding protein IGF2BP1 and the transcriptional regulator SRF
modulate gene expression in cancer. In cancer cells, we demonstrate that IGF2BP1 …

[HTML][HTML] Polycomb repressive complex 1 generates discrete compacted domains that change during differentiation

S Kundu, F Ji, H Sunwoo, G Jain, JT Lee, RI Sadreyev… - Molecular cell, 2017 - cell.com
Master regulatory genes require stable silencing by the polycomb group (PcG) to prevent
misexpression during differentiation and development. Some PcG proteins covalently modify …

[HTML][HTML] Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids

YJ Li, JF Fahrmann, M Aftabizadeh, Q Zhao… - Cell reports, 2022 - cell.com
Overcoming resistance to chemotherapies remains a major unmet need for cancers, such as
triple-negative breast cancer (TNBC). Therefore, mechanistic studies to provide insight for …

[HTML][HTML] Acidosis drives the reprogramming of fatty acid metabolism in cancer cells through changes in mitochondrial and histone acetylation

C Corbet, A Pinto, R Martherus, JPS de Jesus, F Polet… - Cell metabolism, 2016 - cell.com
Bioenergetic preferences of cancer cells foster tumor acidosis that in turn leads to dramatic
reduction in glycolysis and glucose-derived acetyl-coenzyme A (acetyl-CoA). Here, we show …

Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

PK Mazur, A Herner, SS Mello, M Wirth, S Hausmann… - Nature medicine, 2015 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human cancers and
shows resistance to any therapeutic strategy used. Here we tested small-molecule inhibitors …

GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer

P Martinelli, E Carrillo-de Santa Pau, T Cox, B Sainz… - Gut, 2017 - gut.bmj.com
Background and aims The role of GATA factors in cancer has gained increasing attention
recently, but the function of GATA6 in pancreatic ductal adenocarcinoma (PDAC) is …

MYC instructs and maintains pancreatic adenocarcinoma phenotype

NM Sodir, RM Kortlever, VJA Barthet, T Campos… - Cancer discovery, 2020 - AACR
The signature features of pancreatic ductal adenocarcinoma (PDAC) are its
fibroinflammatory stroma, poor immune activity, and dismal prognosis. We show that acute …

p53 directly represses human LINE1 transposons

B Tiwari, AE Jones, CJ Caillet, S Das… - Genes & …, 2020 - genesdev.cshlp.org
Abstract p53 is a potent tumor suppressor and commonly mutated in human cancers.
Recently, we demonstrated that p53 genes act to restrict retrotransposons in germline …